Publicacións (380) Publicacións de José Antonio Páramo Fernández

2024

  1. Comparison of assays measuring extracellular vesicle tissue factor in plasma samples: communication from the ISTH SSC Subcommittee on Vascular Biology

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 10, pp. 2910-2921

  2. Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular

    Clínica e investigación en arteriosclerosis, Vol. 36, Núm. 3, pp. 133-194

  3. Factor XI inhibitors: A new era in antithrombotic therapy

    Medicina Clinica

  4. Immunothrombosis: A key mechanism in the COVID-19 pandemic

    Medicina Clinica

  5. Is tranexamic acid appropriate for all patients undergoing high-risk surgery?

    Current Opinion in Critical Care

  6. Novel biomarkers and psoriasis associated cardiovascular risk

    Archives of Dermatological Research, Vol. 316, Núm. 5

  7. Riesgo trombótico asociado a COVID-19 y diabetes: ¿es PAI-1 el nexo?

    Clínica e investigación en arteriosclerosis, Vol. 36, Núm. 4, pp. 227-228

  8. Role of factor XIII in ischemic stroke: a key molecule promoting thrombus stabilization and resistance to lysis

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 1080-1093

  9. Transcriptomic Analysis of Extracellular Vesicles in the Search for Novel Plasma and Thrombus Biomarkers of Ischemic Stroke Etiologies

    International journal of molecular sciences, Vol. 25, Núm. 8

2023

  1. Critical bleeding-associated to DOACs administration

    Medicina Intensiva, Vol. 47, Núm. 12, pp. 733-735

  2. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives

    Journal of Clinical Medicine, Vol. 12, Núm. 4

  3. Loss of the matrix metalloproteinase-10 causes premature features of aging in satellite cells

    Frontiers in Cell and Developmental Biology, Vol. 11

  4. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 70, Núm. 7, pp. 409-421

  5. Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)

    Medicina Intensiva, Vol. 47, Núm. 8, pp. 454-467

  6. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

    Journal of Clinical Medicine, Vol. 12, Núm. 20

  7. Role of LCN2 in a murine model of hindlimb ischemia and in peripheral artery disease patients, and its potential regulation by miR-138-5P

    Atherosclerosis, Vol. 385

2022

  1. CM-352 Efficacy in a Mouse Model of Anticoagulant-Associated Intracranial Hemorrhage

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1314-1325

  2. Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)

    Medicina Clinica, Vol. 158, Núm. 2, pp. 82-89

  3. Estándares SEA 2022 para el control global del riesgo cardiovascular

    Clínica e investigación en arteriosclerosis, Vol. 34, Núm. 3, pp. 130-179

  4. Hemostatic Biomarkers and Volumetry Help to Identify High-Risk Abdominal Aortic Aneurysms

    Life, Vol. 12, Núm. 6